dalteparin has been researched along with Multiple Organ Failure in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haut, ER | 1 |
| Kamal, MK | 1 |
| Reilly, PM | 1 |
| Stavropoulos, SW | 1 |
1 other study available for dalteparin and Multiple Organ Failure
| Article | Year |
|---|---|
Successful percutaneous retrieval of a swan-ganz catheter entrapped in an inferior vena cava filter.
Topics: Aged, 80 and over; Anticoagulants; Catheterization, Swan-Ganz; Catheters, Indwelling; Colonoscopy; D | 2007 |